MediciNova appoints Kousuke Nakata to board
This article was originally published in Scrip
Executive Summary
Biopharmaceutical company MediciNova has appointed Kousuke Nakata to its board of directors. Mr Nakata is licensing manager of Kissei Pharmaceutical, where he has been employed since 1997. Kissei is MediciNova's biggest shareholder.